TX HB 5467
died on adjournmentRelating to creating the criminal offense of continuous manufacture or delivery of a controlled substance.
Texas · 89th Legislature (2025 Regular Session) · lower
Quick answers
Did TX HB 5467 pass?
No. TX HB 5467 died when the 89th Legislature (2025 Regular Session) adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-05-01): Left pending in subcommittee
What is TX HB 5467 about?
TX HB 5467 is a bill in the 89th Legislature (2025 Regular Session) titled “Relating to creating the criminal offense of continuous manufacture or delivery of a controlled substance.”.
Who sponsors TX HB 5467?
Kitzman is the primary sponsor of TX HB 5467.
- Introduced
- 2025-04-07
- Latest action
- 2025-05-01 — Left pending in subcommittee
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Kitzmanprimary
Committees
Not provided by source.
Action timeline
2025-03-14
Filed
filing
2025-04-07
Read first time
introduction,reading-1
2025-04-07
Referred to Criminal Jurisprudence
referral-committee
2025-04-22
Referred directly to subcommittee by chair
2025-05-01
Scheduled for public hearing in s/c on . . .
2025-05-01
Considered by s/c in public hearing
2025-05-01
Testimony taken/registration(s) recorded in subcommittee
2025-05-01
Left pending in subcommittee
Versions
Documents
Votes
Not provided by source.
Related bills
- Companion bill: SB 1152
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:33:51.767464Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TX&identifier=HB 5467. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.